Cancer drug prevents EMT, metastasis and more
Blocking epithelial–mesenchymal transition (EMT) in tumours reduces their ability to give rise to metastases and sensitises the tumour cells to chemotherapy.
Source: labonline.com.au
Stay updated with breaking news from Etrin 1. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Blocking epithelial–mesenchymal transition (EMT) in tumours reduces their ability to give rise to metastases and sensitises the tumour cells to chemotherapy.